Cargando…

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis

INTRODUCTION: Systemic sclerosis (SSc) is an autoimmune connective tissue disease with distinguished fibrosis of the skin and internal organs. Vascular damage, immune dysregulation and fibroblasts activation contribute to SSc pathogenesis. Peroxisome proliferator-activated receptor γ (PPAR-γ) can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Żółkiewicz, Jakub, Stochmal, Anna, Zaremba, Michał, Rudnicka, Lidia, Czuwara, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874880/ https://www.ncbi.nlm.nih.gov/pubmed/33603610 http://dx.doi.org/10.5114/ada.2019.84746

Ejemplares similares

Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
por: Stochmal, Anna, et al.
Publicado: (2019)

The role of adipokines in systemic sclerosis: a missing link?
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Adiponectin as a novel biomarker of disease severity in alopecia areata
por: Stochmal, Anna, et al.
Publicado: (2021)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor-γ in Amyotrophic Lateral Sclerosis and Huntington's Disease
por: Kiaei, Mahmoud
Publicado: (2008)

The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis
por: Czuwara-Ladykowska, Joanna, et al.
Publicado: (2001)

Future Treatment Options in Systemic Sclerosis—Potential Targets and Ongoing Clinical Trials
por: Bohdziewicz, Anna, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
por: Ohshima, Kousei, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
por: Liu, Huang-Jun, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
por: Zhang, Su, et al.
Publicado: (2015)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
por: Khazaei, Majid
Publicado: (2015)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis
por: Benedusi, Valeria, et al.
Publicado: (2012)

Contact eczema induced by hybrid manicure. The role of acrylates as a causative factor
por: Opaliñska, Sandra, et al.
Publicado: (2021)

3D skin bioprinting: future potential for skin regeneration
por: Pasierb, Anna, et al.
Publicado: (2021)

Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up
por: Misiak-Galazka, Magdalena, et al.
Publicado: (2022)

Ligands of the peroxisome proliferator-activated receptor γ inhibit hepatoce llular carcinoma cell proliferation
por: Jin, Zhe, et al.
Publicado: (2017)

The pathophysiological function of peroxisome proliferator-activated receptor-γ in lung-related diseases
por: Huang, Tom Hsun-Wei, et al.
Publicado: (2005)

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
por: Chan, Marion M., et al.
Publicado: (2012)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Antifibrotic effect by activation of peroxisome proliferator-activated receptor–γ in corneal fibroblasts
por: Pan, Hongwei, et al.
Publicado: (2009)

Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
por: Corzo, Cesar, et al.
Publicado: (2013)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands
por: Mottin, Melina, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor γ Activity is Required for Appropriate Cardiomyocyte Differentiation
por: Peymani, Maryam, et al.
Publicado: (2016)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids
por: Heming, Michael, et al.
Publicado: (2018)

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2018)

EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse
por: Roberts, Lee D, et al.
Publicado: (2009)

The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
por: Stec, Albert, et al.
Publicado: (2023)

Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023)

Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
por: Hoffmann, Aleksandra, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor γ isoforms differentially regulate preadipocyte proliferation, apoptosis, and differentiation in chickens
por: Mu, Fang, et al.
Publicado: (2020)

Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
por: Chiarelli, Francesco, et al.
Publicado: (2008)

Review: Peroxisome Proliferator-Activated Receptor-γ and Its Role in the Development and Treatment of Diabetes
por: Leff, Todd, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_aqvdqvdoqa74h64017obfomu5a